Organization · Venture Capital
Sonder Capital
Sonder Capital is a US-based venture capital firm focused on early-stage investments in medical device, diagnostic, and healthtech startups. The firm emphasizes transformational innovations that can significantly impact patient outcomes.
Overview
What Sonder Capital does
What Sonder Capital is
Sonder Capital is a US-based venture capital firm focused on early-stage investments in medical device, diagnostic, and healthtech startups. The firm emphasizes transformational innovations that can significantly impact patient outcomes.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find Sonder Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Sonder Capital as a funder
Investment thesis
Sonder Capital focuses on transformational innovations in medical devices, diagnostics, and healthtech that can significantly impact patient outcomes and aim for a market capitalization of over $1 billion.
Focus narrative
Sonder Capital invests in early-stage companies within the medical device, diagnostic, and healthtech sectors. The firm seeks transformational innovations that can significantly impact patient outcomes and access to care, focusing on opportunities that could lead to a market capitalization of over $1 billion.
Value beyond capital
Sonder Capital provides hands-on support and strategic guidance to its portfolio companies, leveraging the extensive experience and network of its team to help startups navigate the complexities of the healthcare market and achieve successful exits.
Terms and economics
- Typical check
- $1,000,000–$8,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- Medical Devices · Diagnostics · Healthcare
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Intuitive Surgical, Shockwave Medical, and Auris Health
Portfolio context
Sonder Capital's team has been involved with notable companies such as Intuitive Surgical, Shockwave Medical, Procept Biorobotics, and Auris Health, which have collectively created significant value in the healthcare sector.
Common questions
What to know about Sonder Capital
Upseed classifies Sonder Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.